IPO Track Record CBT Advisors has a proven track record helping private biotech, life sciences, and medical device firms prepare for NASDAQ IPOs through storytelling and strategy. The firm has guided multiple clients to go public, showcasing credibility and a repeatable process attractive to pre IPO companies seeking to de risk IPO readiness.

Biotech Niche Focus The firm specializes in biotech and medical devices, aligning messaging and governance with capital markets expectations, making it a preferred boutique for startups aiming to optimize investor storytelling and readiness before a public listing.

Cross Sell Potential With deep IPO readiness expertise, CBT Advisors can expand services to broader pre IPO packages, including financial narrative, regulatory documentation support, investor communications, and post listing strategy, creating opportunities to cross sell to existing clients as they advance.

Notable Client Portfolio A portfolio featuring high profile IPO clients provides strong case studies and referenceable success stories to accelerate outreach to similar pre IPO biotechs, pharmacology firms, and device companies.

Growth Readiness As a small, high touch consultancy, CBT Advisors can scale through partnerships, subcontractors, or alliances with larger firms to handle larger engagements while maintaining bespoke service, opening channels to win bigger client mandates.